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Abstract: The purpose of this study was to evaluate, under field conditions, the efficacy of an european registered bovine 
concentrated lactoserum (Locatim) in 3 farms with neonatal diarrhoea in calves. A total of 117 healthy Belgian Blue (BB) 
calves were allocated in 2 groups. Two thirds of the calves received Locatim orally immediately after birth and maternal 
colostrum one hour later (treated group), while control calves only received maternal colostrum. Every day during 14 
days, mental status, faeces consistency, suckling reflex and hydration status of each calf were monitored. Individual blood 
samples were assessed for passive transfer and specific Escherichia coli antibodies against strains F5, CS31A, F17 and 
F41. Faecal samples from diarrheic and non diarrheic calves were analysed for rotavirus, bovine coronavirus, Cryptosporidium 
parvum and Escherichia coli F5. Locatim had no significant effect on the onset, duration and incidence of diarrhoea. The 
mean serum IgG concentration of 23.1 ± 7.8 mg/ml indicates a good IgG transfer. Only the CS31A strain titer was 
significantly higher in the treated group. The major identified causative agent of diarrhoea was C. parvum. In conclusion, 
Locatim only has a slight effect when IgG transfer is optimal, but could be justified when specific antibodies lacking in 
colostrum are needed. 
Keywords: Colostrum, specific antibodies, enteropathogens, failure of passive transfer. 
INTRODUCTION 
 The first week of life is a critical period for the newborn 
calf and is generally associated with a mortality rate of 10% 
[1]. Diarrhoea is one of the major causes of mortality in 
newborn calves. The incidence of diarrhoea in calves under 
one month ranges between 15 to 20% [2-4], the greatest risk 
occurring during the first two weeks of life. Neonatal 
diarrhoea is an important source of economic losses for the 
farmer: the cost of prevention and treatment was estimated at 
approximately 33 US dollars per calf and per year [5]. The 
onset of diarrhoea is multifactorial and influenced by various 
environmental, managemental, nutritional and infectious 
factors. Main enteropathogens in neonatal calves are 
rotavirus, bovine coronavirus, Escherichia coli and 
Cryptosporidium parvum (C. parvum) [6]. Given that calves 
are born agammaglobulinemic, they are very receptive to 
neonatal infections. Therefore, the administration of an 
adequate quantity of immunoglobulins G (IgG) within the 
first 24 hours of life is essential. Moreover, the level of 
immunity of the newborn plays an important role on the 
incidence and severity of diarrhoea. The maternal colostrum 
is the first source of IgG to newborn calves. The total  
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amount of IgG absorbed essentially depends on the volume 
of colostrum, the IgG concentration of the ingested 
colostrum, the time between birth and the first feeding and 
the calf’s health status at birth [7]. An inadequate uptake of 
colostrum leads to a partial or a total failure of the passive 
transfer (FPT), which increases morbidity and mortality rates 
in neonatal calves [8]. Nevertheless, colostrum quality not 
only relates to IgG concentration but also to IgG diversity 
which essentially reflects previous exposition of the cow to 
various pathogens. Without sufficient exposure, primiparous 
cows frequently produce a colostrum of lower or inadequate 
IgG diversity. Moreover, different strains of one pathogen, 
like the F5, F41, F17 and CS31A strains of the 
enterotoxigenic E. coli, can simultaneously be involved and 
therefore, antibodies against all these strains are required in 
order to ensure a complete protection [9]. Maternal 
vaccination against different strains of pathogens is one 
suitable preventive method to improve the diversity of IgG. 
However, under field conditions, maternal vaccination is not 
always possible. To enhance the poor protection provided by 
a colostrum with low IgG level or without specific 
antibodies, the use of a colostrum supplement has been 
proposed as a source of exogenous antibodies for calves. 
 The objectives of this study were to evaluate, under field 
conditions, the efficacy of the oral administration of a single 
dose of Locatim, a bovine concentrated lactoserum 
registered for the prevention of neonatal diarrhoea, and to 
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measure the effect of this administration on the calves’ 
serum total IgG and specific IgG concentrations. 
MATERIALS AND METHODOLOGY 
Study Protocol 
 The study protocol was approved by the ethics committee 
of the University of Liege (ethics file n°512). Animals used 
were newborn calves of the hypermuscled Belgian Blue 
(BB) breed from three different farms presenting neonatal 
diarrhoea problems. All calves were born by C-section and 
had to be clinically healthy for inclusion in the protocol. 
Each selected calf was monitored during the first fourteen 
days of life (duration of the study). Farms were visited once 
a week at a regular interval during 17 weeks. Immediately 
after birth, calves were alternately allocated in 2 groups 
(treated or control calves). Sequentially, 2 calves orally 
received 60 ml of an european registered bovine 
concentrated lactoserum (N° EU/2/99/011/001) with a 
certified antibody titer  2.8 log10 for E. coli F5;  3.1 log10 
for E. coli CS31A;  3.2 log10 for E. coli F17;  3.2 log10 for 
E. coli F41;  3.2 log10 for rotavirus and  3.2 log10 for 
bovine coronavirus (Locatim; Biokema; Switzerland) within 
the first hour of life. Each pair of treated calves was followed 
by one control calf. Calves received 4 litres of fresh maternal 
colostrum one hour after Locatim uptake and, for the control 
group, as soon as possible after birth. For each calf, mental 
status, faecal consistency (FC), suckling reflex (SR) and  
 
hydration status (HS) were monitored daily throughout the 
study, according to a scoring table (Table 1). A calf was 
considered diarrheic when the FC was  2. No concurrent 
medication was administered to clinically healthy calves 
during the period of this study. When calves presented signs 
of a clinical disease (diarrhoea or other), a treatment was 
established by the farms’ veterinarian. 
Farms and Animals 
 One hundred seventeen calves, 65 females and 52 males 
were included in the study. A brief description of the 3 farms 
and the repartition of calves by farm are presented in Table 2. 
Data and Samples Collection 
 The colostrum density was assessed at a temperature of 
25°C with a colostrum densitometer (precision of 12.5 g/L). 
For each calf, blood samples were collected between days 3 
and 8 after birth (depending on the fixed day of visit) by 
jugular venipuncture into evacuated serum tubes. Serum was 
separated by centrifugation (1,500 x g during 10 minutes), 
frozen at -20°C and analysed blindly by the Biokema QC 
laboratory (Switzerland) by HPLC for the total IgG content 
and by microagglutination for the titration of specific IgG 
against F5, F17, F41 and CS31A E. coli strains. Faecal 
samples were collected from 28 diarrheic and 13 non-
diarrheic calves directly from rectum and analysed with a 
BioX K071 kit (Bio-X Diagnostics, Belgium) for rotavirus, 
bovine coronavirus, E. coli K99/F5 and C. parvum. 
Table 1. Clinical Scoring Evaluation of Calves for Mental Status, Suckling Reflex, Faecal Consistency and Hydration Status 
 
Score 0 1 2 3 4 





weak but coordinated disordered chewing absent  
Faecal 
Consistency 
normal semi-solid liquid aqueous and abundant  
Hydration 
Status 
normal - enophtalmus of 1-2 mm 
- skin fold persisting 3 to 4 sec. 
- enophtalmus of 3-5 mm 
- skin fold persisting 5 sec. 
- enophtalmus of 6-7mm 
- skin fold persisting 6 to 10 sec.  
- enophtalmus  8 mm 
- persisting skin fold 
 




A B C 
    
Number of calves 44 21 52 
Housing of calves free calves behind dams attached calves beside dams 
free calves allotted by 12/stall or alone in an 
individual box 
Calves feeding suckling calf (free calf) suckling calf (2x/day) bottle and nipple fed (2x2 litres milk/day) 
Reproduction 
artificial insemination and natural 
breeding 
natural breeding 
artificial insemination and embryo transfer on 
Holstein Friesian (HF) heifers  
Vaccination no 
against rotavirus, bovine 
coronavirus and E. coli F5/F41 
no 
Mineral complementation yes yes not for HF heifers 
38    The Open Veterinary Science Journal, 2010, Volume 4 Vandeputte et al. 
Statistical Data Analysis 
 All results were analysed using the program SAS 
(Statistical Analysis System, 6.03 Edition). 
 The animals were classified in 4 groups: with or without 
diarrhoea and treated or control. A chi-square test was used 
to test the differences in numbers between farms and 
between the four calf groups. A Fischer’s Exact Test was 
used to test differences between farms and calf groups of the 
day of diarrhoea onset and the diarrhoea duration and results 
of coprological analysis. The General Linear Model (GLM) 
procedure was used to assess the effects of treatment 
(Locatim or control), FC (diarrheic or non diarrheic) and 
farms as well as the interaction between effects of farms and 
treatment, treatment and FC and farms and FC. All data are 
given as mean ± standard deviation (S.D.) and differences 
were considered statistically significant at the P < 0.05 level. 
RESULTS 
Clinical Scores 
 The number of diarrheic calves was not significantly 
different between treated (n = 27 calves) and control (n = 38 
calves) groups. The day of diarrhoea onset and its duration 
were significantly different between farms, with earlier 
diarrhoea appearing in farm C (day 3) and a shorter duration 
in farm B (1.2 ± 0.5 days). The administration of Locatim 
had no significant effect on the time of onset or on the 
duration of diarrhoea, although a slightly shorter duration 
was observed in the treated group. 
 In comparison with farms A and B, farm C had 
significantly more diarrheic calves presenting mental status 
and SR scores higher than 0. No sign of dehydration was 
observed in the three farms. The mental status, SR and HS 
scores were not significantly different between treated and 
control groups. 
Faecal Samples 
 C. parvum was the most prevalent enteropathogen found, 
present in 31 samples, followed by rotavirus present in 9 
samples. Bovine coronavirus was detected in 4 samples of 
farm A and E. coli F5 in one sample of farm C. C. parvum 
was the only pathogen detected in farm B and was found 
significantly more often in faecal samples of diarrheic 
calves. A mixed infection involving two enteropathogens 
was found in 24% of all faecal samples and was observed in 
32% of diarrheic and 8% of non diarrheic faecal samples. 
Most frequently, the mixed infection was a combination of 
C. parvum and rotavirus. Results of faecal samples analysis 
from diarrheic and non-diarrheic calves for rotavirus, bovine 
coronavirus, E. coli F5 and C. parvum are presented on 
Table 3. 
Colostrum Density, Serum IgG Concentration and 
Specific IgG Transfer 
 Colostrum density and serum IgG concentration were not 
significantly different between farms nor between diarrheic 
and non-diarrheic calves. Mean colostrum density was 103 ± 
17 g/L, colostral density below 75 g/L was observed in 5 
primiparous HF cows from farm C. Mean serum IgG 
concentration was 23.1 ± 7.8 mg/ml. A total FPT was 
diagnosed in 24 calves: in 22 cases (20%) the serum IgG was 
lower than 16 mg/ml and 2 cases (2%) had less than 10 
mg/ml. Only the CS31A E. coli titer was significantly higher 
for the treated group compared to the control group. No 
significant difference of serum IgG concentration and 
specific IgG transfer was found between diarrheic and non 
diarrheic calves. Colostrum density, serum IgG 
concentration and E. coli strains antibodies titers are 
presented in Table 4. 
DISCUSSION 
Clinical Scores 
 In the present study, the Locatim had no significant effect on 
the prevalence of diarrhoea in treated calves. The absence of 
effect can be explained on the one hand by the adequate 
immunity transfer in most of calves and, on the other hand, by 
the high prevalence of C. parvum in diarrheic calves. Adequate 
immunity transfer combined with good surveillance and early 
treatment of diarrheic calves accounts for the short duration of 
diarrhoea in all farms. In addition, the lesser duration of 
diarrhoea in farm B could be explained by a lower population 
density of calves and the vaccination of the dams, although the 
low number of diarrheic calves in this farm limits the 
interpretation of this result. In agreement with a previous report 
[10, 11], trace element deficiencies in pregnant cows are freq-
uently associated with weaker calves at birth and with an 
increase of neonatal mortality and morbidity rates. The HF 
heifers on farm C were not given trace elements, which could 
partly explain the greater sensibility of calves to diarrhoea in 
this farm (earlier diarrhoea onset, higher number of diarrheic 
calves, more serious systemic repercussions observed in many 
diarrheic calves). In the three farms, the lesser severity of 
diarrhoea is confirmed by the absence of significant dehydration 
resulting from a reduced fluid loss via faeces. 
 
Table 3. Results of Faecal Samples Analysis from Diarrheic and Non-Diarrheic Calves for Rotavirus, Bovine coronavirus, E. coli F5 
and C. parvum 
 
Infectious Agent 
Number of Positive Faecal Samples from  
Diarrheic Calves (n = 28) 
Number of Positive Faecal Samples from  
Non-Diarrheic Calves (n = 13) 
Total 
    
Rotavirus 7 2 9 
Bovine coronavirus 3 1 4 
E. coli F5 1 0 1 
C. parvum 24 7 31 
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Faecal Samples 
 C. parvum was detected in 76% of faecal samples, which is 
higher than the prevalence of 32 to 55% observed in diarrheic 
calves in other studies [12-15]. However, a large proportion of 
samples were provided by diarrheic calves in which the 
shedding of C. parvum is showed to be significantly higher [14, 
16]. Rotavirus and bovine coronavirus were found in 
respectively 22% and 10% of faecal samples, which is lower 
than prevalence of respectively 32.5% and 13.6% described in 
diarrheic calves by [12] in Vendée. The adequate immune status 
of calves associated with a reduced excretion of enteropatho-
gens probably plays an important role in this observation. 
 The prevalence of E. coli F5 is lower than that found in 
diarrheic calves by [17] (11.9%) and by [13] (12.5%) in 
Spain, by [18] (3%) in southern Britain, by [15] (5.5%) in 
Switzerland and even in Belgium in 2005 (11.2%) (personal 
communication, ARSIA) but is in agreement with the 
prevalence of 2.6% found in Norway [14]. As for rotavirus 
and bovine coronavirus, the lower detection of E. coli F5 
could be explained by an adequate transfer of the colostral 
immunity and a reduction of the infectious pressure related 
to the Locatim administration. In this study, mixed infections 
were more frequently detected in diarrheic calves and, 
according to [13, 15, 17], the most common mixed infection 
was C. parvum-rotavirus. The low prevalence of the E. coli 
F5 strain and the absence of search for the F41, F17 and 
CS31A E. coli strains restrict the assessment of Locatim 
efficacy against colibacillosis diarrhoea. 
Colostrum Density 
 The mean colostral density of 103 ± 17 g/L was above 
the common threshold value of 75 g/L and reflects the fact 
that beef cows produce smaller amounts of more 
concentrated colostrum [19]. This adequate colostrum density 
provides more than 45 g/L of IgG necessary for a minimal 
ingestion of 100 g of IgG recommended for adequate passive 
immunity transfer [2, 20]. The lower colostrum density observed 
in 5 HF primiparous could largely be related to the parity 
and breed of the cows [8, 21]. 
IgG Serum Concentration 
 The mean serum IgG concentration of 23.1 ± 7.8 mg/ml 
was above threshold values of 10 mg/ml [22] or 16 mg/ml 
[23] classically used to diagnose a total FPT. The prevalence 
of total FPT observed in this study was lower than the 40% 
described in some reports [21] and could be related to a 
timely distribution of an adequate quantity of high quality 
colostrum. Moreover, this adequate serum IgG concentration 
confirms that the C-section commonly performed in the BB 
breed is associated with a good vitality of calves at birth. The 
IgG serum concentration did not differ significantly between 
the treated and the control groups of the three farms, 
probably because the amount of specific IgG (6 g) provided 
by Locatim was negligible in comparison with the amount of 
IgG (± 180 g) provided by colostrum. The effect of Locatim 
could possibly be highlighted with a colostrum containing 
less IgG. 
Specific IgG Transfer 
 Contrary to the study of [24] performed with the same 
lactoserum, the effect of Locatim is only significant for the 
CS31A strain in our study. This lack of significant effect for 
the 3 other E. coli strains could be attributed to a high level 
of specific antibodies in colostrum, likely related to a high 
prevalence of these strains in the three farms. 
Table 4. Mean Colostrum Density, Serum IgG Concentration and E. coli Strains Antibodies Titers in the Three Farms for the 
Diarrheic, Non Diarrheic, Treated and Control Calves 
 






(mg/ml) F5 CS31A F17 F41 
        
Diarrheic 109 (± 15) 21.0 (± 7.1) 2.11 (± 0.30)  1.92 (± 0.33) 4.08 (± 0.26) 2.69 (± 0.40) 
Non diarrheic 107 (± 14) 22.0 (± 7.8) 2.08 (± 0.41)  1.92 (± 0.33) 4.08 (± 0.18) 2.78 (± 0.38) 
Treated 106 (± 15) 22.1 (± 7.5) 2.10 (± 0.35)  2.03* (± 0.33) 4.07 (± 0.26) 2.74 (± 0.43) 
A 
Control 112 (± 13) 19.7 (± 6.7) 2.10 (± 0.31) 1.70 (± 0.19) 4.11 (± 0.19) 2.68 (± 0.30) 
        
Diarrheic  95 (± 19) 28.4 (± 8.1) 2.20 (± 0.21) 1.96 (± 0.33) 4.06 (± 0.13) 2.56 (± 0.39) 
Non diarrheic 103 (± 18) 24.7 (± 9.1) 2.29 (± 0.39) 1.88 (± 0.32) 4.08 (± 0.20) 2.73 (± 0.70) 
Treated 103 (± 17)  27.0 (± 10.2) 2.26 (± 0.39)  1.96* (± 0.29) 4.06 (± 0.21) 2.69 (± 0.72) 
B 
Control 97 (± 20) 22.7 (± 4.5) 2.29 (± 0.29) 1.77 (± 0.34) 4.09 (± 0.15) 2.67 (± 0.45) 
        
Diarrheic 99 (± 18) 21.4 (± 6.1) 2.19 (± 0.23) 1.77 (± 0.24) 4.04 (± 0.24) 2.74 (± 0.37) 
Non diarrheic 100 (± 17) 26.8 (± 8.8) 2.24 (± 0.27) 1.87 (± 0.30) 4.11 (± 0.22) 2.71 (± 0.24) 
Treated 100 (± 17) 22.2 (± 6.1) 2.19 (± 0.22)  1.90* (± 0.27) 4.09 (± 0.26) 2.76 (± 0.36) 
C 
Control 100 (± 19) 25.3 (± 9.0) 2.24 (± 0.27) 1.71 (± 0.23) 4.05 (± 0.21) 2.70 (± 0.28) 
Indicates a statistical significance (p< 0.05). 
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 For example, the antibody titer for the K99 strain is much 
higher than the titer of 0.7 found by [25]. To our knowledge, 
no similar data are available for the F17, F41 and CS31A 
antibodies titers. Nevertheless, these 4 E. coli strains are 
commensal bacteria for the adult cow [26] and they normally 
do not induce the production of antibodies. The reasons of 
this high level of specific antibodies are yet unclear. One 
possible explanation might be the neonatal infection of these 
animals when they were receptive to these E. coli strains. 
The K99 antibody titer in our study seems to be protective 
against K99 colibacillosis. Indeed, in a previous study [27], 
have found that calves with an antibody titer of more than 
0.9 were protected from an experimental ETEC infection. 
CONCLUSION 
 The use of the concentrated lactoserum Locatim could be 
justified in farms where total or partial FPT frequently 
occurs or when a specific IgG not present in the colostrum is 
needed. The significantly higher titer of CS31A antibodies in 
treated calves justifies the Locatim use when this specific 
antibody is deficient in the colostrum. The effect of such 
concentrated lactoserum may be not significant when passive 
transfer of the colostral immunity is successful. Moreover, in 
this study, the high incidence of C. parvum and the low 
activity of colostral antibodies against this pathogen, despite 
a good IgG transfer, may interfere with the Locatim’s 
efficacy for reducing diarrhoea. Finally, further studies are 
needed for a better understanding of high natural antibodies 
levels against some E. coli strains observed in this study. 
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